Advertisement

Topics

Ligand Pharmaceuticals Incorporated Company Profile

09:59 EDT 18th September 2018 | BioPortfolio

Ligand discovers and develops new drugs that address critical unmet medical needs of patients for a broad spectrum of diseases including hepatitis, muscle wasting, Alzheimer's, inflammatory diseases, anemia, COPD, asthma, rheumatoid arthritis and osteoporosis. Ligand's proprietary drug discovery and development programs are based on advanced cell-based assays, gene-expression tools, ultra-high throughput screening and one of the world's largest combinatorial chemical libraries. Ligand has strategic alliances with major pharmaceutical and biotechnology companies, including GlaxoSmithKline, Merck, Pfizer, Roche, Bristol-Myers Squibb, and Cephalon and more than 30 programs are in various stages of development by its partners.


News Articles [426 Associated News Articles listed on BioPortfolio]

Ligand Pharmaceuticals Inc Q2 adjusted earnings Beat Estimates

WASHINGTON (dpa-AFX) - Ligand Pharmaceuticals Inc (LGND) revealed earnings for its second quarter that rose from last year.The company's profit totaled $73.16 million, or $2.99 per share. This com...

Ligand Pharma Makes Offer To Buy Vernalis For About $43 Mln In Cash

LONDON (dpa-AFX) - Ligand Pharmaceuticals Inc. (LGND)and Vernalis plc (VER.L) announce that Ligand has declared its firm intention to acquire the entire issued and to be issued shares of Vernalis ...

Ooivant Licenses Diabetes Drug From Ligand Pharma

Ligand Pharmaceuticals is licensing LGD-6972, a glucagon receptor antagonist (GRA), to Roivant Sciences for $20 million.

Roivant Licenses Diabetes Drug From Ligand Pharma

Ligand Pharmaceuticals is licensing LGD-6972, a glucagon receptor antagonist (GRA), to Roivant Sciences for $20 million.

Ligand In Deal With VenBio To Make OmniA Platform License Accessible

WASHINGTON (dpa-AFX) - Ligand Pharmaceuticals Inc. (LGND) said it has entered into an agreement with venBio Partners, a venture capital group focused on building and funding portfolio companies wi...

Ligand licenses diabetes program to Roivant Sciences

Active deal-maker Ligand Pharmaceuticals has granted Roivant Sciences exclusive global rights to develop…

Ligand Makes $43 Million Bid for Vernalis

US biopharma Ligand Pharmaceuticals has announced its intention to buy UK biotech Vernalis for approximately $43 million.

Notes offering pulls in $650M for Ligand

A notes offering pulled in $650 million for Ligand Pharmaceuticals.  -More- 

PubMed Articles [747 Associated PubMed Articles listed on BioPortfolio]

π-Cation Interactions in Molecular Recognition: Perspectives on Pharmaceuticals and Pesticides.

The π-cation interaction that differs from the cation-π interaction is a valuable concept in molecular design of pharmaceuticals and pesticides. In this Perspective we present an up-to-date review (...

Swimming activity in zebrafish larvae exposed to veterinary antiparasitic pharmaceuticals.

Veterinary antiparasitic pharmaceuticals have been detected in surface waters and several of these pharmaceuticals act on the nervous system on the target organisms implying that neurological effects ...

Assessment of 83 pharmaceuticals in WWTP influent and effluent samples by UHPLC-MS/MS: Hourly variation.

The removal efficiency of pharmaceuticals in wastewater treatment plants (WWTPs) is variable and some of these compounds pass these plants almost intact and others presenting a removal efficiency clos...

Letter--Incorporating Real-World Evidence and Patient Value Criteria into Value-Based Frameworks for Relapsed/Refractory Multiple Myeloma.

Orlowski has received research funding from Amgen, BioTheryX, Bristol-Myers Squibb, Celgene Corporation, and Takeda Pharmaceuticals; honoraria from Amgen, Bristol-Myers Squibb, Celgene Corporation, Ja...

Highly Effective Removal of Nonsteroidal Anti-inflammatory Pharmaceuticals from Water by Zr(IV)-Based Metal-Organic Framework: Adsorption Performance and Mechanisms.

Nonsteroidal anti-inflammatory pharmaceuticals are emerging organic micropollutants in surface water, groundwater, and wastewater, whose removal is very important yet challenging. As a new class of po...

Clinical Trials [425 Associated Clinical Trials listed on BioPortfolio]

Biological Therapy in Treating Patients With Metastatic Melanoma or Metastatic Kidney Cancer

RATIONALE: Biological therapies such as flt3L and CD40-ligand use different ways to stimulate the immune system and stop cancer cells from growing. Biological therapy may be an effective t...

A Phase III Trial of Recombinant Human Apo-2 Ligand for Injection

The trial is to evaluate the efficacy and safety of recombinant human Apo-2 ligand in treating patients with advanced retreated non-small cell lung cancer

Bioequivalence Study of Torrent Pharmaceuticals Ltd's Nebivolol 20 mg Tablet

Subjects to compare the single dose bioavailability of Torrent's Nebivolol Tablets 20 mg and Bystolic®20 mg Tablets of Forest Pharmaceuticals Inc., USA. Dosing periods of studies were sep...

Bioequivalence Study of Torrent Pharmaceuticals's Ltd's Nebivolol 20 mg Tablet

Subjects to compare the single dose bioavailability of Torrent's Nebivolol Tablets 20 mg and Bystolic 20 mg Tablets of Forest Pharmaceuticals Inc., USA. Dosing periods of studies were sepa...

Study Comparing Citalopram Hydrobromide Tablets 40 mg (Torrent Pharmaceuticals Ltd) and RLD Tablets 40 mg (Manufactured By Forest Pharmaceuticals Inc, Missouri) in 24+2 Normal Healthy Male Subjects in Fed Condition

- Objective: - The objective of this study is to compare the rate and extent of absorption of the Test Product, Citalopram Hydrobromide 40 mg (Torrent Pharmaceutical Li...

Companies [1395 Associated Companies listed on BioPortfolio]

Ligand Pharmaceuticals

Ligand is an emerging specialty pharmaceutical company that discovers, develops and markets innovative small molecule drugs to address critical, unmet medical needs. Ligand markets four oncology and d...

Praecis Pharmaceuticals Incorporated (MA)

PRAECIS PHARMACEUTICALS INCORPORATED is a biotechnology company focused on the discovery and development of pharmaceutical products using its proprietary LEAP™ (Ligand Evolution to Active Pharmaceut...

Ligand Pharmaceuticals Incorporated

Ligand discovers and develops new drugs that address critical unmet medical needs of patients for a broad spectrum of diseases including hepatitis, muscle wasting, Alzheimer's, in...

Neurogen Corporation & Ligand Pharmaceuticals

Ligand discovers and develops new drugs that address critical unmet medical needs of patients with muscle wasting, frailty, hormone-related diseases, osteoporosis, inflammatory di...

PRAECIS PHARMACEUTICALS INCORPORATED

PRAECIS PHARMACEUTICALS INCORPORATED is a biopharmaceutical company focused on the discovery and development of novel compounds to address unmet medical needs or improve existing therapies.PRAECIS has...

More Information about "Ligand Pharmaceuticals Incorporated" on BioPortfolio

We have published hundreds of Ligand Pharmaceuticals Incorporated news stories on BioPortfolio along with dozens of Ligand Pharmaceuticals Incorporated Clinical Trials and PubMed Articles about Ligand Pharmaceuticals Incorporated for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Ligand Pharmaceuticals Incorporated Companies in our database. You can also find out about relevant Ligand Pharmaceuticals Incorporated Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Infectious-diseases
Antiretroviral Therapy Clostridium Difficile Ebola HIV & AIDS Infectious Diseases Influenza Malaria Measles Sepsis Swine Flu Tropical Medicine Tuberculosis Infectious diseases are caused by pathogenic...

Rheumatology
Arthritis Fibromyalgia Gout Lupus Rheumatic Rheumatology is the medical specialty concerned with the diagnosis and management of disease involving joints, tendons, muscles, ligaments and associated structures (Oxford Medical Diction...

Psychiatry
Psychiatry is the study of mental disorders and their diagnosis, management and prevention.  Conditions include schizophrenia, severe depression and panic disorders among others. There are pharmaceutical treatments as well as other therapies to help...


Corporate Database Quicklinks



Searches Linking to this Company Record